NOTE: This activity is available only as part of a paid subscription series; it is not available for purchase as a single, stand-alone activity. The goal of this program is to improve management of hematologic and solid malignancies with newly approved therapies. After hearing and assimilating this program, the clinician will be better able to: 1. Recognize adverse effects of newly approved anticancer medications. 2. Compare and contrast umbilical cord blood transplantation with bone marrow transplantation or peripheral blood stem cell transplantation. 3. Use National Comprehensive Cancer Network guidelines to make dose modifications in cases of hepatic or renal dysfunction.
- Provider:Lippincott Continuing Medical Education Institute, Inc.
- Activity Link: https://www.audio-digest.org/Specialties/Oncology
- Start Date: 2024-02-09 06:00:00
- End Date: 2024-02-09 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.5 hours
- MOC Credit Details: ABIM - 1.5 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Medical Oncology
Subscribe
Login
0 Comments
Oldest